FMS May 2024 22.500 call
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.2500 |
| Strike | 22.50 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.1000 - 0.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 128 |
- Reuters
Fresenius Medical sees up to 2% US dialysis growth by year-end
The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United States, could rise by as much as 2% by the end of the year, its CEO said, as the impact of the pandemic on patients fades. Fresenius Medical Care is the world's largest kidney dialysis company, and the fallout from the pandemic - which led to an increase in deaths among patients - has weighed heavily on its shares. Fresenius Medical earlier this year said it anticipated a return to treatment volume growth in the U.S. over the course of 2024, as it slowly recovers from COVID-related deaths among its patients, many of whom suffer from a range of cardiovascular conditions.
Simply Wall St.Fresenius Medical Care's (ETR:FME) Upcoming Dividend Will Be Larger Than Last Year's
The board of Fresenius Medical Care AG ( ETR:FME ) has announced that it will be paying its dividend of €1.19 on the...
Insider MonkeyFresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript May 7, 2024 Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.36, expectations were $0.26. Fresenius Medical Care AG & Co. KGaA isn’t one of the 30 most popular stocks among hedge funds at the end of […]
